Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases.
作者信息
Tikhonova Maria A, Chang Hung-Ming, Singh Sandeep Kumar, Vieau Didier
机构信息
Laboratory of the Experimental Models of Neurodegenerative Processes, Department of Experimental Neuroscience, Scientific Research Institute of Neurosciences and Medicine (SRINM), Novosibirsk, Russia.
Department of Anatomy and Cell Biology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
出版信息
Front Neurosci. 2022 May 16;16:910020. doi: 10.3389/fnins.2022.910020. eCollection 2022.
Abstract
摘要
相似文献
1
Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases.社论：帕金森病和阿尔茨海默病多靶点治疗的实验性与创新性方法
Front Neurosci. 2022 May 16;16:910020. doi: 10.3389/fnins.2022.910020. eCollection 2022.
2
Editorial: Experimental and innovative approaches to multi-target treatment of Parkinson's and Alzheimer's diseases - Volume II.社论：帕金森病和阿尔茨海默病多靶点治疗的实验与创新方法——第二卷
Front Neurosci. 2023 Mar 24;17:1171866. doi: 10.3389/fnins.2023.1171866. eCollection 2023.
3
New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases.新的药物治疗在阿尔茨海默病和帕金森病中显示出神经保护作用。
Neural Regen Res. 2014 Nov 1;9(21):1870-3. doi: 10.4103/1673-5374.145342.
4
Glycation in Parkinson's disease and Alzheimer's disease.帕金森病和阿尔茨海默病中的糖基化作用。
Mov Disord. 2016 Jun;31(6):782-90. doi: 10.1002/mds.26566. Epub 2016 Mar 4.
5
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview.神经退行性疾病研究中的代谢紊乱动物模型：综述
Front Neurosci. 2021 Jan 18;14:604150. doi: 10.3389/fnins.2020.604150. eCollection 2020.
6
Postmenopausal hormone therapy and Alzheimer's disease, dementia, and Parkinson's disease: A systematic review and time-response meta-analysis.绝经后激素治疗与阿尔茨海默病、痴呆和帕金森病：系统评价和时间反应荟萃分析。
Pharmacol Res. 2020 May;155:104693. doi: 10.1016/j.phrs.2020.104693. Epub 2020 Feb 11.
7
Mangiferin: A multipotent natural product preventing neurodegeneration in Alzheimer's and Parkinson's disease models.芒果苷：一种多效天然产物，可预防阿尔茨海默病和帕金森病模型中的神经退行性变。
Pharmacol Res. 2019 Aug;146:104336. doi: 10.1016/j.phrs.2019.104336. Epub 2019 Jul 2.
8
New therapeutic strategy for Parkinson's and Alzheimer's disease.帕金森病和阿尔茨海默病的新治疗策略。
Curr Med Chem. 2010;17(25):2764-74. doi: 10.2174/092986710791859324.
9
Selective delayed response deficits in Parkinson's and Alzheimer's disease.帕金森病和阿尔茨海默病中的选择性延迟反应缺陷。
Arch Neurol. 1986 Sep;43(9):886-90. doi: 10.1001/archneur.1986.00520090026011.
10
Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies.帕金森病痴呆和路易体痴呆中的眼球扫视运动变化。
Brain. 2005 Jun;128(Pt 6):1267-76. doi: 10.1093/brain/awh484. Epub 2005 Mar 17.
引用本文的文献
1
, inflammation and prion protein binding.炎症与朊病毒蛋白结合。
Front Neurosci. 2022 Aug 23;16:822420. doi: 10.3389/fnins.2022.822420. eCollection 2022.
2
Advances on Therapeutic Strategies for Alzheimer's Disease: From Medicinal Plant to Nanotechnology.阿尔茨海默病治疗策略的进展：从药用植物到纳米技术。
Molecules. 2022 Jul 28;27(15):4839. doi: 10.3390/molecules27154839.
本文引用的文献
1
Oligomer-Targeting Prevention of Neurodegenerative Dementia by Intranasal Rifampicin and Resveratrol Combination - A Preclinical Study in Model Mice.经鼻给予利福平与白藜芦醇联合用药对神经退行性痴呆的寡聚体靶向预防作用——模型小鼠的临床前研究
Front Neurosci. 2021 Dec 13;15:763476. doi: 10.3389/fnins.2021.763476. eCollection 2021.
2
α-Synuclein kinetically regulates the nascent fusion pore dynamics.α-突触核蛋白在动力学上调节融合孔的成孔动力学。
Proc Natl Acad Sci U S A. 2021 Aug 24;118(34). doi: 10.1073/pnas.2021742118.
3
Prescribing Aducanumab in the Face of Meager Efficacy and Real Risks.在疗效甚微且存在实际风险的情况下开具阿杜卡单抗处方。
Neurology. 2021 Sep 14;97(11):545-547. doi: 10.1212/WNL.0000000000012452. Epub 2021 Jul 7.
4
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia.甘露寡糖二酸治疗轻中度阿尔茨海默病的 36 周、多中心、随机、双盲、安慰剂对照、平行分组、3 期临床研究。
Alzheimers Res Ther. 2021 Mar 17;13(1):62. doi: 10.1186/s13195-021-00795-7.
5
Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.改善阿尔茨海默病树突棘的药理学策略。
J Alzheimers Dis. 2021;82(s1):S91-S107. doi: 10.3233/JAD-201106.
6
Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer's Disease.海洋天然产物、多靶点治疗与阿尔茨海默病的药物 repurposed 制剂
Pharmaceuticals (Basel). 2020 Sep 11;13(9):242. doi: 10.3390/ph13090242.
7
Modulation of the expression of genes related to the system of amyloid-beta metabolism in the brain as a novel mechanism of ceftriaxone neuroprotective properties.头孢曲松通过调节脑内淀粉样β代谢相关基因表达发挥神经保护作用的新机制。
BMC Neurosci. 2018 Apr 19;19(Suppl 1):13. doi: 10.1186/s12868-018-0412-5.
8
Challenges for Alzheimer's Disease Therapy: Insights from Novel Mechanisms Beyond Memory Defects.阿尔茨海默病治疗面临的挑战：来自记忆缺陷之外新机制的见解。
Front Neurosci. 2018 Feb 6;12:37. doi: 10.3389/fnins.2018.00037. eCollection 2018.
9
Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.治疗阿尔茨海默病的多靶点策略——联合治疗药物的特点和结果。
J Ethnopharmacol. 2018 Apr 6;215:42-73. doi: 10.1016/j.jep.2017.12.015. Epub 2017 Dec 14.
10
Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence.头孢曲松治疗对加速衰老大鼠模型认知和神经元缺陷的神经保护作用。
Behav Brain Res. 2017 Jul 14;330:8-16. doi: 10.1016/j.bbr.2017.05.002. Epub 2017 May 6.
Zotero 插件